De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
NXGN Overzicht aandelen
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Geen risico's gedetecteerd voor NXGN uit onze risicocontroles.
NextGen Healthcare, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$23.94 |
| 52 Week Hoogtepunt | US$23.98 |
| 52 Week Laag | US$15.23 |
| Bèta | 0.77 |
| 11 maand verandering | 0.46% |
| 3 maanden verandering | 41.66% |
| 1 Jaar Verandering | 19.28% |
| 33 jaar verandering | 52.97% |
| 5 jaar verandering | 51.04% |
| Verandering sinds IPO | 13,828.73% |
Recent nieuws en updates
Recent updates
Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 49% Undervaluation?
Aug 24
NextGen Healthcare, Inc. Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 27Investors Will Want NextGen Healthcare's (NASDAQ:NXGN) Growth In ROCE To Persist
Jul 13We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Jun 08Calculating The Fair Value Of NextGen Healthcare, Inc. (NASDAQ:NXGN)
May 19What Does NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Share Price Indicate?
Mar 14We Think NextGen Healthcare (NASDAQ:NXGN) Can Manage Its Debt With Ease
Feb 27Is NextGen Healthcare, Inc. (NASDAQ:NXGN) Expensive For A Reason? A Look At Its Intrinsic Value
Dec 08These Return Metrics Don't Make NextGen Healthcare (NASDAQ:NXGN) Look Too Strong
Oct 27At US$17.85, Is It Time To Put NextGen Healthcare, Inc. (NASDAQ:NXGN) On Your Watch List?
Sep 30NextGen Enterprise solution to be used by NY-based health center
Sep 28NextGen Healthcare, Inc.'s (NASDAQ:NXGN) Intrinsic Value Is Potentially 75% Above Its Share Price
Sep 07NextGen Healthcare (NASDAQ:NXGN) Is Finding It Tricky To Allocate Its Capital
Jul 29NextGen Healthcare Non-GAAP EPS of $0.16 in-line, revenue of $153.3M in-line, 2023 revenue outlook below estimates
Jul 26Is It Too Late To Consider Buying NextGen Healthcare, Inc. (NASDAQ:NXGN)?
May 17NextGen At A Crossroads
Oct 13Is There An Opportunity With NextGen Healthcare, Inc.'s (NASDAQ:NXGN) 44% Undervaluation?
Jun 29Rendement voor aandeelhouders
| NXGN | US Healthcare Services | US Markt | |
|---|---|---|---|
| 7D | 0.04% | -2.2% | 0.4% |
| 1Y | 19.3% | -2.8% | 32.6% |
Rendement versus industrie: NXGN overtrof de US Healthcare Services industrie, die het afgelopen jaar een rendement 1 % opleverde.
Rendement versus markt: NXGN overtrof de US markt, die het afgelopen jaar een rendement opleverde van 34.1 %.
Prijsvolatiliteit
| NXGN volatility | |
|---|---|
| NXGN Average Weekly Movement | 5.2% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: De aandelenkoers van NXGN is de afgelopen 3 maanden volatiel geweest.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van NXGN is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1974 | 2,783 | David Sides | www.nextgen.com |
NextGen Healthcare, Inc. Samenvatting
| NXGN fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$1.61b |
| Inkomsten(TTM) | -US$6.21m |
| Inkomsten(TTM) | US$695.05m |
2.3x
P/S-verhouding-258.5x
Koers/WinstverhoudingIs NXGN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| NXGN resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$695.05m |
| Kosten van inkomsten | US$344.33m |
| Brutowinst | US$350.73m |
| Overige uitgaven | US$356.94m |
| Inkomsten | -US$6.21m |
Laatst gerapporteerde inkomsten
Sep 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.093 |
| Brutomarge | 50.46% |
| Nettowinstmarge | -0.89% |
| Schuld/Eigen Vermogen Verhouding | 63.2% |
Hoe presteerde NXGN op de lange termijn?
Bekijk historische prestaties en vergelijking